CoQ10 is synthesized endogenously and can be obtained through diet and supplements. With certain conditions, such as hypertension (HTN), the body cannot synthesize enough CoQ10, prompting the need for supplementation. As CoQ10 levels decline and oxidative stress increases with age, CoQ10 supplementation has shown therapeutic benefits in aging-related disorders.
A study published in JACC: Advances seeks to move research forward toward identifying whether severe elevations in LDL-C are associated with increased atherosclerosis in lean, otherwise healthy people following KDs. This one-year prospective study followed 100 subjects classified as…
Research is unveiling the importance of two interconnected components of healthy aging: Supporting the mitochondria and maintaining a healthy inflammatory response. In fact, inflammation is considered such a significant part of the aging process that the term “inflammaging” was coined. Counteracting inflammaging is linked to cognitive and heart health asRead
The challenge is that most CoQ10 supplements are not well-absorbed. Furthermore, they need to be taken with a fatty meal for optimal absorption. As I like to tell my patients, “The most expensive supplement that an individual can take is one you need, yet is not absorbing.”
The statements mentioned in this content have not been evaluated by the FDA, and are not intended to prevent, diagnosis, or treat any disease. Always work with your personal healthcare provider. Worldwide, cardiovascular disease is the number one cause of death with 17.9 million people dying annually from disordersRead
Plastic is ubiquitous in today’s environment, and we see negative repercussions on cardiovascular health. A recent New England Journal of Medicine article showed that patients with microplastics and nanoplastics (MNPs) detected in carotid plaques had higher risk of myocardial infarction, stroke, or death from any cause.
Apolipoprotein B (ApoB) is a crucial structural protein found in atherogenic lipoproteins, including low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a) [Lp(a)]. Unlike other lipid markers such as LDL-C, which measure cholesterol content, ApoB provides a direct count of the number of atherogenic lipoprotein particles, makingRead
Protecting endothelial function is central to a comprehensive cardiovascular care protocol—here’s how ubiquinol helps. With the number of deaths from cardiovascular diseases on the rise, heart health remains a growing concern for practitioners. Over the past three decades, cardiovascular-related deaths have been steadily increasing, and in 2021, heart diseaseRead
Advanced lipid testing goes beyond traditional cholesterol panels, providing detailed insights into cardiovascular risk factors like Lp(a), apoB, and LDL-P. Discover how these tests support risk stratification, personalized treatments, and improved patient outcomes.
Lipoprotein(a), abbreviated as LP(a), is a unique lipoprotein particle that has garnered increasing attention in recent years due to its significant role in cardiovascular health. As an emerging biomarker, LP(a) is now recognized as a crucial factor in assessing a patient’s risk for atherosclerosis, coronary artery disease (CAD), and otherRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
